Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

BUY
$59.18 - $69.99 $1.06 Million - $1.25 Million
17,904 Added 5968.0%
18,204 $0
Q1 2021

May 06, 2021

BUY
$59.31 - $78.82 $8,896 - $11,822
150 Added 100.0%
300 $21,000
Q1 2021

May 05, 2021

BUY
$59.31 - $78.82 $8,896 - $11,822
150 New
150 $60,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.06B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Abundance Wealth Counselors Portfolio

Follow Abundance Wealth Counselors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abundance Wealth Counselors, based on Form 13F filings with the SEC.

News

Stay updated on Abundance Wealth Counselors with notifications on news.